Neurological adverse events post allogeneic hematopoietic cell transplantation: major determinants of morbidity and mortality

Background Despite advances in the field, diagnosis and management of the wide spectrum of neurological events post allogeneic hematopoietic cell transplantation (alloHCT) remain challenging. Therefore, we investigated their incidence, diagnosis, management and long-term prognosis in alloHCT recipients.